Table 1 Demographic and clinical characteristics of participants at baseline
From: Vitamin D3 supplementation and treatment outcomes in patients with depression (D3-vit-dep)
Intervention group (n = 28) | Control group (n = 34) | Total (n = 62) | |
|---|---|---|---|
Female, n (%) | 21 (75.0) | 23 (67.7) | 47 (69.1) |
Age (years), mean (SD) | 39.6 (13.5) | 38.7 (11.4) | 39.1 (12.3) |
Normal 25(OH)D (≥ 50 nmol/L), n (%) | 10 (35.6) | 13 (38.2) | 23 (35.5) |
Insufficient 25(OH)D (25–50 nmol/L), n (%) | 11 (39.3) | 11 (32.4) | 22 (35.5) |
Deficient 25(OH)D (< 25 nmol/L), n (%) | 7 (25.0) | 10 (29.4) | 17 (27.4) |
SSRI, n (%)* | 17 (60.7) | 12 (35.3) | 29 (46.8) |
SNRI, n (%) | 12 (42.9) | 18 (52.9) | 30 (48.4) |
Depression (HAM-D17), mean (SD) | 18 (6) | 18 (6) | 18 (6) |